Nio, CVS Health Should Rise; Stellantis Weak
30 Setembro 2024 - 10:09AM
IH Market News
U.S.-listed shares of Nio (NYSE:NIO) are moving sharply higher
in pre-market trading after the Chinese electric vehicle maker
announced a 13.3 billion yuan investment in Nio China from
strategic investors.
Healthcare company CVS Health (NYSE:CVS) may also see initial
strength after a report from the Wall Street Journal said hedge
fund Glenview Capital Management will meet top executives on Monday
to propose ways the struggling company can improve its
operations.
On the other hand, shares of Stellantis (NYSE:STLA) are seeing
substantial pre-market weakness after the automaker cut its
full-year adjusted operating profit margin outlook.
Stellantis NV (NYSE:STLA)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Stellantis NV (NYSE:STLA)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024